Search the Newsreel

Earnings call transcript: Finolex Industries posts mixed Q1 2026 results, shares fall

Enerflex Ltd. EFX Earnings Beat Estimates by 28.7%

Enerflex Boosts Backlog and Cash Flow as It Targets U.S. Compression Growth

Enerflex Falls 5.6% as Q2 Profit Halves Even With a Record Backlog

Enerflex backlog climbs to $1.5B, with most expected to convert in 12 months

Enerflex reported Q2 2026 financial results, with revenue of $582 million and adjusted EBITDA of $128 million. The company's ES backlog grew to $1.5 billion, and it generated $32 million in free cash flow, reducing net debt to $455 million. Enerflex also extended its …

Lexicon Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $3.86, Implies 57% Upside

Lexicon Pharmaceuticals, Inc.'s average stock price target has been raised from $3.77 to $3.86 by 5 analysts, with forecasts ranging from $2 to $6 per share. This updated target suggests a potential upside of approximately 57% based on the August 5 closing price. The …

Amundi Has $4.62 Million Stake in Teleflex Incorporated $TFX

Amundi increased its stake in Teleflex Incorporated (NYSE:TFX) by 325.2% in the first quarter, now holding 38,606 shares valued at approximately $4.62 million. Teleflex exceeded second-quarter expectations with adjusted EPS of $1.76 and revenue of $570.3 million, and raised its fiscal 2026 EPS guidance …

Plexus Corp (NASDAQ: PLXS) lifts sales to $1.30B as free cash flow turns negative

Plexus Corp. reported strong Q3 2026 results with net sales reaching $1.30 billion, a 28.1% increase year-over-year, and nine-month sales up 19.0% to $3.54 billion. Despite the revenue growth and a strong return on invested capital (ROIC) of 14.9%, the company's free cash flow …

California State Teachers Retirement System Acquires 5,728 Shares of Plexus Corp. $PLXS

The California State Teachers Retirement System (CalSTRS) increased its stake in Plexus Corp. (NASDAQ:PLXS) by 22.3% in the first quarter, purchasing 5,728 additional shares to now own 31,393 shares valued at $6.36 million. This comes as Plexus reported strong quarterly results, exceeding EPS and …

Rolex Rings Q1 Results: Standalone Unaudited Financials for FY26 Published

Enerflex declares $0.0425 dividend

* Enerflex (EFXT [https://seekingalpha.com/symbol/EFXT]) declares $0.0425/share quarterly dividend [https://seekingalpha.com/pr/20609507-core-natural-resources-reports-second-quarter-2026-results], in line with previous. * Forward yield [https://seekingalpha.com/symbol/EFXT/dividends/yield?source=news_bullet] 0.82% * Payable Sept. 2; for shareholders of record Aug. 19; ex-div Aug. 19. * See EFXT Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/EFXT/dividends?source=news_bullet] MORE ON …

Alexandria Real Estate Equities (ARE) Stock Still Looks Like A Bargain

Alexandria Real Estate Equities (ARE) stock appears undervalued based on various valuation tests, including a Discounted Cash Flow (DCF) model and a Price-to-Sales (P/S) comparison. The company's share price has fallen significantly, yet its intrinsic value suggests a potential upside. Investors need to assess …

Precision Trading with Enerflex Ltd (EFXT) Risk Zones

This article provides a precision trading analysis for Enerflex Ltd (EFXT) using AI models, outlining distinct trading strategies for various risk profiles and holding periods. It highlights a positive near-term sentiment that may counter a mid-term weak bias, alongside elevated downside risk due to …

Enerflex (EFXT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, August 6, 2026 at 10 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Paul E. MahoneySenior Vice President and Chief Financial Officer - Preet DhindsaVice President of Corporate Development and Capital Markets - Jeffrey Eric …

PRIMECAP Management discloses 6.38% Flex Ltd. (FLEX) ownership in 13G/A update

PRIMECAP Management Co. has filed an amended 13G/A, disclosing a 6.38% ownership stake in Flex Ltd. (FLEX). The firm beneficially owns 23,358,875 shares, with sole voting power over 23,116,755 shares and sole dispositive power over all its holdings. This filing indicates a significant passive …

Boralex Receives all Regulatory Approvals for Arrangement with Brookfield and La Caisse

MONTRÉAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Corporation") (TSX: BLX) announced today that it has received all regulatory approvals required in connection with the closing of the previously-announced plan of arrangement under the Canada Business Corporations Act (the "Arrangement") …

Teleflex Incorporated Announces Quarterly Dividend of $0.34 (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend of $0.34 per share, payable on September 30th to shareholders of record on August 14th. This represents an annualized dividend of $1.36, yielding 1.0%, and is well-covered by earnings with a payout ratio of 9.7%. The medical …

Earnings call transcript: Teleflex beats Q2 2026 EPS, but shares slip premarket

Lexicon Pharmaceuticals Q2 Earnings Call Highlights

Teleflex Inc 2Q 2026: Revenue $570.33M, EPS $2.28— 10-Q Summary

Teleflex Inc. reported its second-quarter 2026 results, with revenue increasing to $570.33 million, a 28.9% rise year-over-year, largely due to the acquired VI Business and increased product volumes. However, diluted EPS fell to $2.28 from $2.77, and net income decreased by 18.7%. The company …

FLEX LNG Ltd (FLNG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for FLEX LNG Ltd (FLNG), indicating its current earnings forecast score and industry ranking. It highlights analyst ratings, price targets, and expected revenue and EPS for upcoming quarters. Most analysts recommend a "Sell" for FLNG stock.

Press Release: Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Lexicon Pharmaceuticals reported its second-quarter 2026 financial results, which included total revenues of $15.5 million and a net loss of $28.3 million. The company also provided updates on its clinical development programs, notably the successful completion of the Phase 2 RELIEF-DIA study for LX9200 …

Teleflex Q2 2026 slides: mixed results amid integration challenges

Teleflex reported mixed Q2 2026 results with strong performance in Vascular and Surgical segments, but challenges in integrating its Interventional business led to a reduced revenue outlook. Despite lower revenue guidance, the company raised its adjusted EPS guidance due to share repurchases and lower …

Alexandria Real Estate Equities Inc. stock underperforms Thursday when compared to competitors

Shares of Alexandria Real Estate Equities Inc. (ARE) dropped 3.23% on Thursday, closing at $48.48. This underperformance occurred during a generally negative trading session for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. The company's stock …

Enerflex Ltd. reports results for the quarter ended June 30 - Earnings Summary

Enerflex Ltd. has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides an overview of the company's financial performance for this period. To access the full details, readers are directed to TradingView for unlimited access …

Why Enerflex Ltd. stock is plummeting today

Rolex Rings to host investor meetings at Equirus conference in Mumbai

FMR LLC (LXRX) discloses 11.7% Lexicon Pharmaceuticals stake in amended 13G

FMR LLC filed an amended Schedule 13G, disclosing a beneficial ownership of 11.7% in Lexicon Pharmaceuticals, Inc. common stock, totaling 51,782,044.66 shares. Abigail P. Johnson also holds sole dispositive power over the same amount. Notably, Fidelity Growth Company Commingled Pool accounts for 5.6% of …

FMR LLC discloses 5.3% FLEX LTD (FLEX) ownership, 19.53M shares controlled

FMR LLC has disclosed a 5.3% ownership stake in FLEX LTD (FLEX), amounting to 19,530,636.28 shares of common stock as of June 30, 2026. The firm holds sole voting power for 19,289,621.89 shares and sole dispositive power for all 19,530,636.28 shares. Abigail P. Johnson …

Teleflex (NYSE:TFX) Issues FY 2026 Earnings Guidance

Dimensional Fund Advisors LP Buys 303,398 Shares of Enerflex Ltd. $EFXT

Dimensional Fund Advisors LP significantly increased its stake in Enerflex Ltd. by 33.5% in the first quarter, acquiring an additional 303,398 shares, bringing its total ownership to 1.21 million shares valued at approximately $25.3 million. Institutional investors now collectively own 46.47% of the company. …

Teleflex (TFX) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Teleflex (TFX) reported revenue of $570.33 million, down 27% over the same period last year. EPS came in at $1.76, compared to $3.73 in the year-ago quarter. The reported revenue represents a surprise of +1.89% over the Zacks …

Earnings Flash (LXRX) Lexicon Pharmaceuticals, Inc. Reports Q2 Revenue $692,000, vs. FactSet Est of $4.0M

Lexicon Pharmaceuticals, Inc. (LXRX) reported Q2 revenue of $692,000, significantly missing the FactSet estimate of $4.0 million. The biopharmaceutical company also announced its Q2 2026 earnings call for August 6, 2026, and earnings results for the second quarter and six months ended June 30, …

Earnings Flash (EFX) Enerflex Ltd. Reports Q2 Revenue $582.0M, vs. FactSet Est of $606.8M

Enerflex Ltd. (EFX) reported its second-quarter revenue at $582.0 million, falling short of FactSet's estimate of $606.8 million. The article also provides recent news and analyst adjustments for Equifax Inc., highlighting various price target changes from different financial institutions. Additionally, it offers a company …

Teleflex (TFX) Surpasses Q2 Earnings and Revenue Estimates

Teleflex (TFX) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $3.73 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Earnings Flash (LXRX) Lexicon Pharmaceuticals Posts Q2 Loss $0.07 a Share, vs. FactSet Est of $0.05 Loss

Lexicon Pharmaceuticals (LXRX) reported a Q2 loss of $0.07 per share, which was worse than FactSet's estimated loss of $0.05 per share. The company also announced Q2 revenue of $692,000, falling short of FactSet's estimate of $4.0 million. Lexicon Pharmaceuticals is focused on the …